tetradecanoylphorbol acetate and astragaloside a

tetradecanoylphorbol acetate has been researched along with astragaloside a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Geng, Y; He, C; Li, L; Li, Y; Liang, X; Ma, Y; Shu, G; Song, X; Ye, G; Yin, L; Yin, Z; Yue, G; Zhang, R; Zhao, Y; Zou, Y	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and astragaloside a

Article	Year
Astragaloside IV inhibits PMA-induced EPCR shedding through MAPKs and PKC pathway. Immunopharmacology and immunotoxicology, 2017, Volume: 39, Issue:3 Topics: Antigens, CD; Endothelial Protein C Receptor; Extracellular Signal-Regulated MAP Kinases; Human Umbilical Vein Endothelial Cells; Humans; MAP Kinase Signaling System; Protein Kinase C; Receptors, Cell Surface; Saponins; Tetradecanoylphorbol Acetate; Triterpenes	2017

Article

Year

Astragaloside IV inhibits PMA-induced EPCR shedding through MAPKs and PKC pathway.

Immunopharmacology and immunotoxicology, 2017, Volume: 39, Issue:3

Topics: Antigens, CD; Endothelial Protein C Receptor; Extracellular Signal-Regulated MAP Kinases; Human Umbilical Vein Endothelial Cells; Humans; MAP Kinase Signaling System; Protein Kinase C; Receptors, Cell Surface; Saponins; Tetradecanoylphorbol Acetate; Triterpenes

2017